Literature DB >> 8527708

Detection of hepatitis B virus precore stop codon mutants by selective amplification method: frequent detection of precore mutants in hepatitis B e antigen positive healthy carriers.

S Nakahori1, O Yokosuka, T Ehata, W L Chuang, F Imazeki, Y Ito, M Ohto.   

Abstract

The precore region of hepatitis B virus (HBV) is indispensable for secretion of e antigen protein. Therefore, the precore stop codon mutants may play an important role in the process of e antigen seroconversion. However, the presence of the mutants in hepatitis B e antigen positive carriers has not been fully studied because of difficulties in detecting the mutants in the presence of large amounts of wild-type viruses. To overcome this, a sensitive method has been developed to detect the presence of G to A stop codon mutants at codon 28 of precore region. Primers for polymerase chain reaction (PCR) were devised to introduce restriction enzyme site Sty I for wild-type viruses and Dde I for the mutants. The amplification products with these primers were digested with Sty I to exclude the products from wild-type viruses. The remaining amplicon from precore mutants were re-amplified, and the presence of precore mutant was confirmed with Dde I digestion. The presence of precore mutants was examined in 61 HBV carriers by the method combining PCR and restriction enzyme digestion. Approximately 0.1% of precore mutant DNA among 10(6) copies of wild-type virus DNA was detectable by this method. The presence of the precore mutants was detected in seven of 10 (70%) e antigen positive asymptomatic carriers, and in 29 of 36 (81%) e antigen positive patients with chronic liver diseases, and in all 15 (100%) anti-e antibody positive patients with chronic liver diseases. This study revealed that a small amount of the precore mutants was present in the majority of HBV carriers.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8527708     DOI: 10.1111/j.1440-1746.1995.tb01594.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  5 in total

Review 1.  Natural history of hepatitis B virus infection: pediatric perspective.

Authors:  Yen-Hsuan Ni
Journal:  J Gastroenterol       Date:  2010-09-02       Impact factor: 7.527

2.  Whole-exome sequencing of human pancreatic cancers and characterization of genomic instability caused by MLH1 haploinsufficiency and complete deficiency.

Authors:  Linghua Wang; Shuichi Tsutsumi; Tokuichi Kawaguchi; Koichi Nagasaki; Kenji Tatsuno; Shogo Yamamoto; Fei Sang; Kohtaro Sonoda; Minoru Sugawara; Akio Saiura; Seiko Hirono; Hiroki Yamaue; Yoshio Miki; Minoru Isomura; Yasushi Totoki; Genta Nagae; Takayuki Isagawa; Hiroki Ueda; Satsuki Murayama-Hosokawa; Tatsuhiro Shibata; Hiromi Sakamoto; Yae Kanai; Atsushi Kaneda; Tetsuo Noda; Hiroyuki Aburatani
Journal:  Genome Res       Date:  2011-12-07       Impact factor: 9.043

3.  Two sensitive PCR-based methods for detection of hepatitis B virus variants associated with reduced susceptibility to lamivudine.

Authors:  M I Allen; J Gauthier; M DesLauriers; E J Bourne; K M Carrick; F Baldanti; L L Ross; M W Lutz; L D Condreay
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

4.  Novel mutant-enriched sequencing identified high frequency of PIK3CA mutations in pharyngeal cancer.

Authors:  Wanglong Qiu; Guo-Xia Tong; Spiros Manolidis; Lanny G Close; Adel M Assaad; Gloria H Su
Journal:  Int J Cancer       Date:  2008-03-01       Impact factor: 7.396

5.  High frequency of the 1896 precore mutation in patients and blood donors with hepatitis B virus infection from the Indian subcontinent.

Authors:  Perumal Vivekanandan; Priya Abraham; Gopalan Sridharan; George Chandy; Ramachandran V Shaji; Dolly Daniel; Sukanya Raghuraman; Hubert Darius Daniel; Thenmozhi Subramaniam
Journal:  Mol Diagn       Date:  2004
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.